FDA Approved: TERCONAZOLE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Terconazole from Cosette Pharmaceuticals, under ANDA 077553, enabling the marketed generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Terconazole (Terconazole)

Snippet

SUPPL AP for TERCONAZOLE (TERCONAZOLE)